Ultrasound-guided Pudendal Nerve Block for Pain After Hemorrhoidectomy
NCT ID: NCT05889962
Last Updated: 2024-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-10-26
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emergency Physician-performed Ultrasound-guided Femoral Nerve Blocks in Patients With Hip Fractures.
NCT05969561
The Analgesic Efficacy of Ultrasound Guided Adductor Canal Block Versus 4 in 1 Block in Patients Undergoing Knee Surgeries: A Comparative Randomized Double Blinded Study .
NCT05794685
Efficacy of Pericapsular Nerve Group (PENG) Block for Hip Surgeries
NCT06144931
Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery
NCT04110132
Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty
NCT04480320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Placebo group: Patients will receive pudendal nerve block with normal saline.
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pudendal block group
Receiving bilateral pudendal nerve block with 0.5% ropivacaine (10 ml each side)
Pudendal nerve block
Patients who are randomized in the pudendal block group will receive bilateral pudendal nerve block with ropivacaine.
Placebo group
Receiving bilateral pudendal nerve block with normal saline (10 ml each side)
Placebo block
Patients who are randomized in the placebo group will receive bilateral pudendal block with normal saline.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pudendal nerve block
Patients who are randomized in the pudendal block group will receive bilateral pudendal nerve block with ropivacaine.
Placebo block
Patients who are randomized in the placebo group will receive bilateral pudendal block with normal saline.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 20 to 65 years old
* American Society of Anesthesiologists (ASA) classification I\~III
* Receiving Ferguson hemorrhoidectomy under spinal anesthesia
Exclusion Criteria
* Drug abuse
* Coagulopathy
* An active infection at the injection site
* Patient refusal
* BMI ≥ 30
* Pregnancy
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuan-Wen Lee, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N202303039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.